| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.087 | 0.003 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.006 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |